February 16, 2023
Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform
Media
February 16, 2023
Targovax ASA: Fourth quarter 2022 results
February 15, 2023
Aprea Therapeutics Announces Phase II SBIR Award from the National Cancer Institute (NCI)
February 14, 2023
Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger
February 13, 2023
Fusion Pharmaceuticals To Acquire Phase 2 Program For 225Ac-PSMA I&T, A Radiopharmaceutical Targeting Metastatic Castrate Resistant Prostate Cancer
February 13, 2023
Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split
February 09, 2023
Spruce Biosciences Announces $53.6 Million Private Placement Financing
February 09, 2023
Invitation to presentation of the year-end report 2022
February 08, 2023
Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
February 08, 2023
Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February
